STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
Reported by STAT News · all stories from statnews.com
Editorial digest
This report examines the last medical devices designated as 'breakthrough' that will receive specific favorable treatment from Medicare. It details the end of a particular pathway for accelerated coverage.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/12/2026
STAT+: New documents raise more questions about Medicare’s AI prior-authorization experiment
Newly surfaced records prompt growing scrutiny regarding Medicare's pilot initiative using artificial intelligence for coverage approvals.
- Trusted health newsroom11/5/2026
STAT+: Medicare delays controversial remote patient monitoring rule to 2029
Federal regulators have postponed a contentious Medicare remote patient monitoring policy update until 2029.
- Trusted health newsroom11/6/2026
STAT+: After Medicare punts RPM overhaul to 2029, advocates see window to fight back
Advocates plan to challenge Medicare's remote monitoring overhaul after officials postponed the policy update to 2029.
- Trusted health newsroom11/5/2026
STAT+: What the midterms could mean for the future of health AI
Upcoming midterm election outcomes could reshape regulatory policies and federal oversight for medical artificial intelligence technologies.
- Trusted health newsroom11/3/2026
STAT+: FDA, CMS look to collaborate with states on health AI
Federal regulators at the FDA and CMS plan to partner with state authorities regarding medical artificial intelligence.
- Trusted health newsroom10/29/2026
STAT+: The EPIC investigation, and a Teladoc surprise
New reporting examines an inquiry into Epic alongside an unexpected update involving telehealth company Teladoc.